Armed with new proof-of-concept data showing that its in vivo base-editing therapy BEAM-302 can correct the gene mutation in alpha-1 antitrypsin deficiency (AATD), Beam Therapeutics is seeking to ...

Yeckel] recently put the finishing touches on an ambitious implementation of a simple D-STAR (Digital Smart Technologies for Amateur Radio) transceiver using some very accessible and affordable ...

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.

There is currently no schedule data. The NFL Schedule will be released in May.